The continuous orchestration platform for DevOps, Opsera, today announced its enterprise-wide SaaS DevOps capabilities intended to manage and modernize software releases.
On top of this, the company has released a new study that demonstrates the need for a single, enterprise-wide SaaS DevOps platform with annual SaaS spending reported as $125 billion in 2021.
According to the company, this platform brings disparate and siloed data together under a singular focus and alleviates the need to build separate development teams, metadata, configurations, profiles, permissions, and packages and release management tactics for end-to-end visibility spanning the SaaS DevOps ecosystem.
Additionally, Opsera’s multi-SaaS and multi-cloud architecture works to allow enterprises to leverage the platform in order to accelerate SaaS DevOps maturity in several SaaS applications.
Enterprises are also enabled to leverage Opsera’s no-code platform and reusable microservices to improve the velocity of releases.
“The increased pace of SaaS and the public cloud replacing on-premises solutions will have a global impact on IT operations,” said Vernon Keenan, senior industry analyst at SalesforceDevops.net and author of the study. “As organizations add more critical SaaS applications to their inventories, the need for a cohesive SaaS management strategy, or SaaS DevOps, will grow dramatically in the next five years. With today’s announcement, Opsera is well positioned to help enterprises to streamline their SaaS DevOps and help improve their agility, velocity, security posture and visibility.”
Based on Keenan’s report, SaaS revenue will continue to grow at a 25% rate annually and will reach $279 billion by 2024. The study also showed that 35 new SaaS companies have entered the market since 2018, demonstrating the part that SaaS application expansion has in this growth.
To learn more and read the full report, see here.
The post Opsera introduces new SaaS DevOps capabilities appeared first on SD Times.
from SD Times https://ift.tt/1hFIeW2
Comments
Post a Comment